MAP1B rescues LRRK2 mutant-mediated cytotoxicity

Molecular Brain

Volumn 7, Issue 1, 2014, Pages

  Chan, Sharon L ^a   Chua, Ling Ling ^a   Angeles, Dario C ^b   Tan, Eng King ^a  

^a NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Apoptosis; LC1; LRRK2; MAP1B; Phosphorylation

Indexed keywords

LEUCINE RICH REPEAT KINASE 2; MICROTUBULE ASSOCIATED PROTEIN 5;

APOPTOSIS; ARTICLE; AUTOPHOSPHORYLATION; CELL VIABILITY; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MUTANT MEDIATED CYTOTOXICITY; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; UPREGULATION;

CELL DEATH; CELL LINE; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; MUTANT PROTEINS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN TRANSPORT; PROTEIN-SERINE-THREONINE KINASES; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 84899658839     PISSN: None     EISSN: 17566606     Source Type: Journal    
DOI: 10.1186/1756-6606-7-29     Document Type: Article

References (13)

1. Parkinson's disease: mechanisms and models. Dauer W, Przedborski S, Neuron 2003 39 889 909 10.1016/S0896-6273(03)00568-3 12971891 (Pubitemid 37130207)
2. Staging of brain pathology related to sporadic Parkinson's disease. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E, Neurobiol Aging 2003 24 197 211 10.1016/S0197-4580(02)00065-9 12498954 (Pubitemid 36007810)
3. LRRK2 in Parkinson's disease: genetic and clinical studies from patients. Kumari U, Tan EK, FEBS J 2009 276 6455 6463 10.1111/j.1742-4658.2009.07344.x 19804413
4. Leucine-rich repeat kinase 2 gene-associated disease: redefining genotype-phenotype correlation. Wider C, Dickson DW, Wszolek ZK, Neurodegener Dis 2010 7 175 179 10.1159/000289232 20197701
5. Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity. West AB, Moore DJ, Choi C, Andrabi SA, Li X, Dikeman D, Biskup S, Zhang Z, Lim KL, Dawson VL, Dawson TM, Hum Mol Genet 2007 16 223 232 17200152 (Pubitemid 46179004)
6. LRRK2 signaling pathways: the key to unlocking neurodegeneration? Berwick DC, Harvey K, Trends Cell Biol 2011 21 257 265 10.1016/j.tcb.2011.01.001 21306901
7. LRRK2 kinase regulates synaptic morphology through distinct substrates at the presynaptic and postsynaptic compartments of the Drosophila neuromuscular junction. Lee S, Liu HP, Lin WY, Guo H, Lu B, J Neurosci 2010 30 16959 16969 10.1523/JNEUROSCI.1807-10.2010 21159966
8. MAP1B is encoded as a polyprotein that is processed to form a complex N-terminal microtubule-binding domain. Hammarback JA, Obar RA, Hughes SM, Vallee RB, Neuron 1991 7 129 139 10.1016/0896-6273(91)90081-A 1712602
9. Novel features of the light chain of microtubule-associated protein MAP1B: microtubule stabilization, self interaction, actin filament binding, and regulation by the heavy chain. Togel M, Wiche G, Propst F, J Cell Biol 1998 143 695 707 10.1083/jcb.143.3.695 9813091 (Pubitemid 28512565)
10. DJ-1 can inhibit microtubule associated protein 1 B formed aggregates. Wang Z, Zhang Y, Zhang S, Guo Q, Tan Y, Wang X, Xiong R, Ding J, Chen S, Mol Neurodegener 2011 6 38 10.1186/1750-1326-6-38 21645326
11. Kinase activity is required for the toxic effects of mutant LRRK2/dardarin. Greggio E, Jain S, Kingsbury A, Bandopadhyay R, Lewis P, Kaganovich A, van der Brug MP, Beilina A, Blackinton J, Thomas KJ, Ahmad R, Miller DW, Kesavapany S, Singleton A, Lees A, Harvey RJ, Harvey K, Cookson MR, Neurobiol Dis 2006 23 329 341 10.1016/j.nbd.2006.04.001 16750377 (Pubitemid 44097032)
12. NIH Image to ImageJ: 25 years of image analysis. Schneider CA, Rasband WS, Eliceiri KW, Nat Methods 2012 9 671 675 10.1038/nmeth.2089 22930834
13. Mutations in LRRK2 increase phosphorylation of peroxiredoxin 3 exacerbating oxidative stress-induced neuronal death. Angeles DC, Gan BH, Onstead L, Zhao Y, Lim KL, Dachsel J, Melrose H, Farrer M, Wszolek ZK, Dickson DW, Tan EK, Hum Mutat 2011 32 1390 1397 10.1002/humu.21582 21850687